Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1934 1
1940 2
1942 1
1945 3
1946 9
1947 13
1948 22
1949 17
1950 45
1951 86
1952 94
1953 82
1954 81
1955 71
1956 99
1957 125
1958 160
1959 147
1960 124
1961 131
1962 176
1963 260
1964 398
1965 245
1966 222
1967 278
1968 283
1969 325
1970 314
1971 341
1972 352
1973 300
1974 323
1975 329
1976 354
1977 332
1978 329
1979 381
1980 435
1981 426
1982 440
1983 502
1984 571
1985 569
1986 590
1987 576
1988 640
1989 758
1990 707
1991 777
1992 726
1993 808
1994 785
1995 887
1996 881
1997 934
1998 999
1999 965
2000 983
2001 1104
2002 1078
2003 1144
2004 1374
2005 1579
2006 1697
2007 1870
2008 1928
2009 2121
2010 2366
2011 2527
2012 2798
2013 3096
2014 3419
2015 3416
2016 3756
2017 3791
2018 3938
2019 3996
2020 4987
2021 5455
2022 5265
2023 4976
2024 5108
2025 5662
2026 3021

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,913 results

Results by year

Filters applied: in the last 1 year. Clear all
Page 1
Pulmonary hypertension in 2025: next steps?
Parikh K. Parikh K. Curr Opin Cardiol. 2025 Jul 1;40(4):251-258. doi: 10.1097/HCO.0000000000001228. Epub 2025 May 2. Curr Opin Cardiol. 2025. PMID: 40401433 Review.
PURPOSE OF REVIEW: To review recent updates in pediatric pulmonary hypertension with a special focus on recent recommendations from the World Symposium of Pulmonary Hypertension (WSPH). RECENT FINDINGS: The third pediatric specific WSPH report highligh …
PURPOSE OF REVIEW: To review recent updates in pediatric pulmonary hypertension with a special focus on recent recommendations …
Best Practices for Right Heart Catheterization in the Diagnosis of Pulmonary Hypertension.
Matusov Y, Kolaitis NA, Geft D, DesJardin J, Barnett C, Hage A, De Marco T, Lewis MI. Matusov Y, et al. Chest. 2025 Sep;168(3):763-779. doi: 10.1016/j.chest.2025.05.009. Epub 2025 May 16. Chest. 2025. PMID: 40383185 Review.
Right heart catheterization is the gold standard for the diagnosis of pulmonary hypertension. There are variations in practice and several pitfalls introducing errors in diagnosis that can significantly affect treatment. Errors in assessing the correct pulmonary …
Right heart catheterization is the gold standard for the diagnosis of pulmonary hypertension. There are variations in practice …
Macrophage-Derived LCN2 Promotes Methamphetamine-Induced Pulmonary Hypertension.
Zhou J, Xu Z, Peng DB, Li X, Chang S, Duan K, Jiang Y, Gu C, Peng X, Xie WB. Zhou J, et al. Hypertension. 2025 Aug;82(8):1355-1367. doi: 10.1161/HYPERTENSIONAHA.124.24548. Epub 2025 Jun 23. Hypertension. 2025. PMID: 40546080
BACKGROUND: Methamphetamine (METH), a novel amphetamine-type psychostimulant, is recognized as a risk factor for pulmonary hypertension (PH). Macrophage activation is a key event in pulmonary vascular remodeling and PH progression, but the specific mechanisms …
BACKGROUND: Methamphetamine (METH), a novel amphetamine-type psychostimulant, is recognized as a risk factor for pulmonary hyperte …
Neutrophil-Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension.
Guo Y, Gao Z, Zhang R, Long H, Zhang M, Liu L, An Z, Shi Y, Cui Y, Jia Y, Wang L, Sun Y, Liu J, Wang W. Guo Y, et al. Adv Sci (Weinh). 2025 Aug;12(31):e04397. doi: 10.1002/advs.202504397. Epub 2025 Jun 10. Adv Sci (Weinh). 2025. PMID: 40492585 Free PMC article.
Pulmonary hypertension (PH) is a severe disease characterized by pulmonary vascular remodeling in which various immune cells play a critical role in vascular remodeling, although the details are still vague. ...These findings suggest that neutrophil-derived S …
Pulmonary hypertension (PH) is a severe disease characterized by pulmonary vascular remodeling in which various immune …
[Chronic Thromboembolic Pulmonary Hypertension].
Wiedenroth CB, Bikou O, von Bonin S, Halank M, Held M, Konstantinidis S, Mayer E, Mayer L, Omlor A, Seyfarth HJ, Ulrich S, Wilkens H, Guth S. Wiedenroth CB, et al. Pneumologie. 2025 Oct;79(10):808-818. doi: 10.1055/a-2625-4950. Epub 2025 Oct 6. Pneumologie. 2025. PMID: 41052534 Review. German.
Chronic thromboembolic pulmonary hypertension (CTEPH) occurs as a late complication of acute pulmonary embolism (PE). Scar-like narrowing of the pulmonary circulation resulting from insufficient thrombolysis and variable microvasculopathy increase the …
Chronic thromboembolic pulmonary hypertension (CTEPH) occurs as a late complication of acute pulmonary embolism (PE). S …
Pulmonary Hypertension Associated With Interstitial Lung Diseases.
Jose A, Sood N, Elwing JM, Akkanti B, Bajwa A, Bernardo R, Estrada RA, Sharma M, Soto FJ, Tonelli AR, Verma D, Vintch J, Sahay S, Shlobin OA; Pulmonary Vascular Disease (PVD) Section. Jose A, et al. Chest. 2026 Jan;169(1):220-229. doi: 10.1016/j.chest.2025.07.4107. Epub 2025 Sep 10. Chest. 2026. PMID: 40939937 Free PMC article. Review.
Pulmonary hypertension (PH) is frequently encountered in patients with fibrotic ILDs and poses unique difficulties for both diagnosis and management. Patients with ILD-associated pulmonary hypertension (ILD-PH) are complex, often ailing and presenting …
Pulmonary hypertension (PH) is frequently encountered in patients with fibrotic ILDs and poses unique difficulties for both di …
Management of chronic thromboembolic pulmonary hypertension.
Wiedenroth CB, Jenkins D, Brenot P, Lang IM, Matsubara H, Pepke-Zaba J, Channick R, Jais X, Simonneau G, Delcroix M, Kerr K, de Perrot M, Mayer E, Pretorius V, Mahmud E, Poch D, Shimokawahara H, Steinberg ZL, Madani M. Wiedenroth CB, et al. J Heart Lung Transplant. 2025 Jul;44(7S):S8-S14. doi: 10.1016/j.healun.2025.02.1691. J Heart Lung Transplant. 2025. PMID: 40653350 Review.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe and progressive disease. Three treatment modalities are available: pulmonary endarterectomy, balloon pulmonary angioplasty, and pulmonary hypertension (PH) medical therapy. …
Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe and progressive disease. Three treatment modalities are avai …
Diagnosis of chronic thromboembolic pulmonary hypertension.
Jais X, Tapson V, Fernandes TM, Fadel E, Kligerman S, Pepke-Zaba J, Kerr KM, Fedullo PF, Yang JZ, Madani MM, Lang IM, Kim NH. Jais X, et al. J Heart Lung Transplant. 2025 Jul;44(7S):S1-S7. doi: 10.1016/j.healun.2025.02.1688. J Heart Lung Transplant. 2025. PMID: 40653349 Review.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe complication of acute pulmonary embolism (PE), affecting approximately 2.7% of PE survivors. ...The mechanisms precluding a complete resolution of PE are not yet fully understood and include ch …
Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe complication of acute pulmonary embolism (PE), affect …
Pulmonary hypertension: diagnostic aspects-what is the role of imaging?
Ali HJ, Guha A. Ali HJ, et al. Curr Opin Cardiol. 2025 Sep 1;40(5):311-318. doi: 10.1097/HCO.0000000000001241. Epub 2025 Jun 27. Curr Opin Cardiol. 2025. PMID: 40600429 Review.
PURPOSE OF REVIEW: The role of imaging in diagnosis of pulmonary hypertension is multifaceted, spanning from estimation of pulmonary arterial pressures, understanding pulmonary artery-right ventricular interaction, and identification of the cause. The …
PURPOSE OF REVIEW: The role of imaging in diagnosis of pulmonary hypertension is multifaceted, spanning from estimation of …
Frailty in Pulmonary Hypertension: A Multidimensional Comorbidity.
Sridhar M, Tauquir A, Sahay S, Tonelli AR, Al-Naamani N, Cajigas HR. Sridhar M, et al. Ann Am Thorac Soc. 2025 Aug;22(8):1115-1125. doi: 10.1513/AnnalsATS.202410-1009FR. Ann Am Thorac Soc. 2025. PMID: 40239026 Review.
Pulmonary hypertension is a complex and irreversible pulmonary vascular disease with a significant impact on patients' lives. ...In this narrative review, we describe the pathobiology of frailty in pulmonary hypertension, assessment tools, the i …
Pulmonary hypertension is a complex and irreversible pulmonary vascular disease with a significant impact on patients' …
5,913 results